These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37230945)

  • 1. Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland.
    Vinter N; Halminen O; Lehto M; Airaksinen KEJ; Andersson T; Wändell P; Holzmann M; Rutherford OC; Halvorsen S; Cordsen P; Frost L; Johnsen SP
    Basic Clin Pharmacol Toxicol; 2023 Aug; 133(2):168-178. PubMed ID: 37230945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical Variation in the Use of Oral Anticoagulation and Clinical Outcomes among Patients with Atrial Fibrillation in Denmark, Sweden, and Finland.
    Frost L; Halminen O; Lehto M; Airaksinen KEJ; Andersson T; Wändell P; Holzmann M; Cordsen P; Vinter N; Johnsen SP
    TH Open; 2023 Apr; 7(2):e133-e142. PubMed ID: 37288117
    [No Abstract]   [Full Text] [Related]  

  • 3. Inequality in oral anticoagulation use and clinical outcomes in atrial fibrillation: a Danish nationwide perspective.
    Christesen AMS; Vinter N; Mortensen LS; Fenger-Grøn M; Johnsen SP; Frost L
    Eur Heart J Qual Care Clin Outcomes; 2018 Jul; 4(3):189-199. PubMed ID: 30102321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Gadsbøll K; Staerk L; Fosbøl EL; Sindet-Pedersen C; Gundlund A; Lip GYH; Gislason GH; Olesen JB
    Eur Heart J; 2017 Mar; 38(12):899-906. PubMed ID: 28110293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
    Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcomes of patients with atrial fibrillation and major bleeding complications: from the TREAT-AF study.
    Perino AC; Kaiser DW; Lee RJ; Fan J; Askari M; Schmitt SK; Turakhia MP
    J Interv Card Electrophysiol; 2021 Oct; 62(1):133-142. PubMed ID: 32986177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Giehm-Reese M; Johansen MN; Kronborg MB; Jensen HK; Gerdes C; Kristensen J; Johannessen A; Jacobsen PK; Djurhuus MS; Hansen PS; Riahi S; Nielsen JC
    Int J Cardiol; 2021 Jun; 333():110-116. PubMed ID: 33647366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.
    Larsen LK; Ovesen C; Frost L; Damgaard D; Christensen H; Johnsen SP
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):112-120. PubMed ID: 31855254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
    Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Langén VL; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Hartikainen J; Airaksinen KEJ; Lehto M
    PLoS One; 2022; 17(10):e0276612. PubMed ID: 36315505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.
    Palomäki A; Kiviniemi T; Hartikainen JE; Mustonen P; Ylitalo A; Nuotio I; Hartikainen P; Jaakkola J; Luite R; Airaksinen KE
    Clin Cardiol; 2016 Aug; 39(8):471-6. PubMed ID: 27240121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
    Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
    Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
    Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
    Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
    Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
    Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.